Insay di fild fɔ layf sayɛns, ol ol tɛm na wan big risach tɔpik. as risεch pan di mεkanism dεm fכ ol de kכntinyu fכ dip, di rol we nikotinamid adenine dinucleotide (NAD+) de ple fכ di anti-aging prכsεs dεn gεt mכr atεnshכn. Rid Mɔ

sins dεn dכn diskovri am insay 1999, ghrelin dכn kכmכt as fכkal pכynt fכ risεch insay di layf sayns dεm bikoz fכ in yכnik fysiolojikal fכnshכn dεm εn brayt bayolojikal ifekt dεm. Rid Mɔ

We yu de du ɛksɛsayz, bɔku tɛm we yu taya, dat kin mek yu nɔ ebul fɔ bia wit ɛksesaiz. di nכmal fכnshכn fכ di enεji mεtabolism path dεm implεnt fכ mεnten di εksεsayz kapasiti. Rid Mɔ

Slu-PP-332, we na sεntetik εstrojen rεsεptכr-rεlatεd כfεn rεsεptכr (ERR) agonist, kin gεt fayn ifekt pan mכtalman hεlth insay plεnti we dεm. Rid Mɔ

ripa pεptida dεn dכn sho sכm sכm pכtεnshal in di fild fכ ripa tisu εn rigεnεreshכn. as ripa pεptida, Chonluten de ple rol fכ rεgεl sεlyul aktiviti εn fכ promuot di tisu ripa. Rid Mɔ

Bam15, as selektiv maytochondrial uncoupler, dεn bin aplay in mεtabolik-rεlatεd risεch fil dεm insay di rεsεnt ia, we de gi nyu tritmεnt opshכn fכ difrεn mεtabolik sik dεm. Rid Mɔ

Tayp 2 dayabitis (T2D) na wan kכmכn krεse mεtabolik dizכrd wae de kכl insulin rεsistεns εn nכ insulin sekreshכn, we de mek di blɔd glukכs lεvεl go כp. Rid Mɔ

insay di fil dεm fכ mεdisin εn bayoloji, di inflammatory rεspכns na kכmpleks difensiv riakshכn fכ di bכdi to difrεn injuri stimuli dεm. Rid Mɔ

Fɔ fat dɔn bi wan siriɔs pɔblik wɛlbɔdi prɔblɛm ɔlsay na di wɔl, wit bɔku bad bad tin dɛn we kin apin to pipul dɛn bɔdi, lɛk fɔ mek dɛn gɛt sik dɛn we de mek dɛn at ɛn blɔd, dayabitis, ɛn ɔda tin dɛn we nɔ de mɛn. Insay di las ia, GLP-1 drɔgs dɔn kɔmɔt as prɔmis tritmɛnt opshɔn pan di fild fɔ ɔbisiti mɛnejɛmɛnt. Rid Mɔ